TABLE 4.

Patient Measurements Before and After Application of a Comprehensive Natural Medicine Regimen to Treat Parkinson’s Disease

Outcome measuresf	Pre-first treatmenta	Post-first treatmentb	Pre-second treatmentc	Post-second treatmentd	Post-third treatmente
I. Motor evaluation total score	14	11	12	4	3
II. Complications of therapy total score	9	1	5	1	0
III. Mental total score	1	0	0	0	0
IV. Activities of daily living total score	10	4	5	0	0
V. Hoehn & Yahr stagingsg	3	2	2	2	2
VI. Scoring of motor fluctuationsh	C	A	B	A	A
SF-36 subscalesf
General health	55	87	—	72	77
Physical functioning	45	55	—	65	80
Role-physical (RP)	25	75	—	75	100
Vitality	40	45	—	30	55
Physical summary	34.48	43.48	—	43.82	52.18

^aOn first admission to the Center for Chronic Disorders (CCD).

^b6 weeks after first CCD program.

^cOn second admission to CCD.

^d2 weeks after second CCD program.

^e6 weeks after third CCD program.

^fI-VI are from Rabey et al. Evaluation of the Short Parkinson’s Evaluation Scale: A new friendly scale for the evaluation of Parkinson’s disease in clinical drug trials. Clinical Neuropharmacology.1997;20:322–337. Except for V and VI, scores for individual items ranged from 0 (no disease) to 3 (severest disease).

^g0 = no signs of disease; 1 = unilateral disease; 2 = bilateral disease; 3 = some postural instability, mild-moderate bilateral disease, physically independent; 4 = severe disability but still able to walk or stand unassisted; 5 = wheelchair bound or bedridden unless aided.

^hA = no motor fluctuations or dyskinesias; B = dyskinesias and/or akinetic episodes and/or freezing gait that affect daily life; C = dyskinesias and/or akinetic episodes and/or freezing episodes that affect daily activities; D = dyskinesias and/or akinetic episodes and/or freezing gait that significantly affect activities of daily life; require considerable assistance for activities of daily life.